Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

You searched for:

Trial Testimony in a Maryland Bone Marrow Transplant Suit Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Trial Testimony in a Maryland Bone Marrow Transplant Suit Marilyn Mannisto …
Oncology's Future under Health Care Reform Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Oncology's Future under Health Care Reform Lee E. Mortenson To cite this article: Lee …
RO Model PC and TC Payment Methodology Workbooks While the Association of Community Cancer Centers (ACCC) is pleased that CMS has issued a delay in the Radiation Oncology (RO) Model implementation date, we remain committed to helping programs and practices understand the financial impact of the model and to demonstrate to the Centers for Medicare & Medicaid Services (CMS) and Congressional champions …
MJ05-Meet-ACCC-New-President
MA13-We-Hear-You
Board-of-Trustees-FAQs-2014
Fine-Tuning Physician Compensation Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Fine-Tuning Physician Compensation John S. Hoff To cite this article: John S. Hoff (1996) …
MA12-Coding
JA08-Vascular-Access-Procedures
A forthright conversation between the treating clinician, patient and family members on the importance of self-reporting adverse events must take place prior to consideration of combination immunotherapy.
SO07-Partnering-with-Cancer
OI | Vol. 37, No. 1, 2022 | accc-cancer.org 1 compliance 2022 Oncology Coding Update BY TERI BEDARD, BA, RT(R)(T), CPC • C56.3: Malignant neoplasm of bilateral ovaries • C79.63: Secondary malignant neoplasm of bilateral ovaries. There are also new codes related to anaplas- tic large cell lymphoma for breast cancer. Added codes and guidance include the following: • C84.79A: Anaplastic …
Avoiding Common Pitfalls in Radiation Oncology Coding Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Avoiding Common Pitfalls in Radiation Oncology Coding R. Lawrence White To cite …
þÿ UNEDITED UNREVISED DRAFT 2.23.21 BILL TOPIC: "Prescription Drug Affordability Review Board" DEADLINES: Finalize by: FEB 24, 2021 File by: MAR 2, 2021 First Regular Session Seventy-third General Assembly STATE OF COLORADO DRAFT LLS NO. 21-0497.02 Richard Sweetman x4333 SENATE BILL Senate Committees House Committees A BILL FOR AN ACT 101 CONCERNING THE COLORADO …
JF02-Selecting-Your-Cancer-Registry-Software
OI | Vol. 36, No. 1, 2021 | accc-cancer.org 23 S pencer Cancer Center provides its scattered rural population in east central Alabama a suite of services that match those of comprehensive cancer centers in large urban areas. Located on the main campus of East Alabama Medical Center, the stand-alone facility opened in June 2019. A recognized provider of high-quality holistic cancer care, Spencer …
OI | Vol. 36, No. 1, 2021 | accc-cancer.org 23 S pencer Cancer Center provides its scattered rural population in east central Alabama a suite of services that match those of comprehensive cancer centers in large urban areas. Located on the main campus of East Alabama Medical Center, the stand-alone facility opened in June 2019. A recognized provider of high-quality holistic cancer care, Spencer …
ASCO® DIRECT Highlights 2019: Breast Cancer Target Audience The primary target audience for this meeting comprise the multidisciplinary clinical cancer care team members including, but not limited to medical, surgical, and radiation oncologists; fellows; gastroenterologists; nephrologists; neurologists; pathologists; pulmonologists; radiologists; researchers; oncology nurse practitioners and oncology …
How do I determine whether something qualifies as an innovation? ACCC is looking for innovations that advance the goals of improving the delivery of quality cancer care. Take a look at previous award winners for the scope of projects that have been honored. Can anyone in my cancer program apply for an award? Anyone who is affiliated with ACCC as a Cancer Program Member is eligible to apply for …
The following heat maps display chronic lymphocytic leukemia (CLL) incidence rates by state and metropolitan area and below them, institutions with specialization for treating CLL.